Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers from the Division win Oxford Sparks competition to have an animation created about research into Alzheimer's disease.

Before Christmas 2017, Oxford Sparks ran a competition which offered research groups the chance to win an animation about their research. The competition was won by members of the Alzheimer’s Research UK Oxford Drug Discovery Institute – Dr Hazel Hall-Roberts, a neuroimmunology cell biologist, and Keely Jones, the research group administrator – who will receive a bespoke animation to illustrate and explain their research. Alzheimer’s Research UK Oxford Drug Discovery Institute is based within the Nuffield Department of Clinical Medicine. 

The animation will explain the complex elements of Alzheimer's research, and highlight the importance of developing new drugs to treat the disease. The researchers will collaborate with professional animators to produce this short video about their research, and receive a dedicated social media campaign to publicise it. 

The other winner of the competition was Brooke Johnson, who is based in the Department of Earth Sciences in MPLS. 

Oxford Sparks is a public-facing online project that aims to bring alive the University's science research for wider audiences. Through a diverse range of digital content and activities they showcase and explain research, and encourage the public to engage with scientific research. They have already developed several animations with Medical Sciences researchers, and you can see some examples on their website

Find out more (MPLS news item)

 

 

Similar stories

Oxford University academics recognised in Queen’s Birthday Honours

The pioneering work of members of the University, including research into tackling the Coronavirus pandemic, has been recognised in The Queen's Birthday Honours List.

Two Oxford Professors elected as EMBO Members

Professor Robert Klose and Professor Ervin Fodor are two of 64 life scientists to be elected to The European Molecular Biology Organization (EMBO).

Scientists make DNA breakthrough which could identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine at Oxford University have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

AI endoscopy enables 3D surface measurements of pre-cancerous condition in oesophagus

Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer.

The COVID-19 International Modelling Consortium (CoMo Consortium) enters a new phase

Created in March 2020 to assist policymakers to make use of existing evidence in mathematical and epidemiological models to inform strategies for minimising the impact of COVID-19, the CoMo Consortium brings together mathematical modellers, epidemiologists, health economists and public health experts from more than 40 countries across Africa, Asia and South and North America.

New Head of the Department of Psychiatry – Professor Belinda Lennox

Professor Belinda Lennox has been welcomed to the role of Head of the Department of Psychiatry at the University of Oxford and will take over leadership in October 2021.